Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Interactions with the Agencies During Drug Development

April 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, NDA, drug development

 NDA would like to invite you to join  Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …
News
Press release
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sandoz, appointment, pharma

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …
News
blood-1813410_960_720

Heart drugs show promise in stroke and dementia

April 25, 2019 Research and Development angina, cilostazol, dementia, heart drugs, isosorbide mononitrate, stroke

Drugs for heart disease and angina have shown promise as preventative treatments for stroke and dementia, according to scientists from …
News

Pharma boosts lobby spending in first quarter of 2019

April 24, 2019 Research and Development PhRMA, Trump, USA, congress, lobbying, lobbyists, pharma

The Pharmaceutical Research and Manufacturers of America (PhRMA) trade lobbyists have spent near record levels on lobbying in the first …
News

Working Life: Dr Todd Hobbs, Vice President and Chief Medical Officer, Novo Nordisk

April 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Working Life, feature, pharma

Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …
Feature
abbvie_0

AbbVie’s Skyrizi snatches up FDA approval in moderate to severe plaque psoriasis

April 24, 2019 Research and Development, Sales and Marketing AbbVie, FDA, Skyrizi, US, pharma, psoriasis

AbbVie has revealed that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab-rzaa) has received marketing authorisation in the US from the FDA …
News

Eli Lilly sell Chinese rights to two antibiotics in deal worth $375 million

April 24, 2019 Research and Development

US firm Eli Lilly has agreed to sell the Chinese rights to two of its antibiotics, Ceclor (cefaclor) and Vancocin …
News
636674328233382711-sd-071718-opioids-b-metro

Former pharma wholesaler execs face criminal charges over opioid crisis

April 24, 2019 Research and Development Litigation, RDC, Rochester Drug Cooperative, opioid crisis, opioids

Laurence Doud III, the former CEO of New York-based Rochester Drug Co-operative (RDC) – one of the largest drug distributors …
News
teva_copy

Teva terminates Ajovy at Phase 3 in episodic cluster headache

April 24, 2019 Research and Development Teva, ajovy, headache, pharma

Israeli pharmaceutical firm Teva has announced its intention to terminate further development of its calcitonin gene-related peptide (CGRP) inhibitor Ajovy …
News

Novartis reveals promising interim Phase 3 data for gene therapy Zolgensma in spinal muscular atrophy

April 18, 2019 Research and Development Novartis, Zolgensma, pharma

Novartis has revealed new interim data from its Phase 3 trial investigating the efficacy of its gene therapy Zolgensma (onasemnogene …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma

This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …
News

CBD could be used to deliver drugs into the brain, research shows

April 18, 2019 Research and Development BBB, CBD, CNS, brain, drug delivery, neuroscience

Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …
News

Doctors cure ‘bubble boy syndrome’ using modified version of HIV

April 18, 2019 Research and Development HIV, SCID-X1, gene therapy, immunodeficiency, immunology

Doctors at St. Jude Children’s Research Hospital have been able to treat patients with X-linked severe combined immunodeficiency (SCID-X1) – …
News
andrew_long

Insys Therapeutics names current CFO Andrew Long as company’s new CEO

April 17, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insys Therapeutics, appointment, pharma

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Appointment
icl

Imperial College London researchers developing tech to monitor dementia patients at home

April 17, 2019 Research and Development dementia, imperial college london, pharma

Researchers at Imperial College London are hard at work developing technology to aid the lives of dementia patients in their …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025